both	O
were	O
ejected	O
from	O
the	O
game	O
,	O
but	O
ferris	person-athlete
refused	O
to	O
go	O
.	O

négo	person-athlete
was	O
a	O
part	O
of	O
the	O
team	O
that	O
won	O
the	O
2010	O
uefa	event-sportsevent
european	event-sportsevent
under-19	event-sportsevent
football	event-sportsevent
championship	event-sportsevent
on	O
home	O
soil	O
.	O

radek	O
dvorak	O
would	O
finish	O
just	O
behind	O
smyth	person-athlete
with	O
50	O
points	O
,	O
while	O
ethan	person-athlete
moreau	person-athlete
and	O
raffi	person-athlete
torres	person-athlete
would	O
each	O
score	O
20	O
goals	O
.	O

he	O
participated	O
at	O
the	O
winter	event-sportsevent
olympics	event-sportsevent
in	O
1980	O
,	O
1984	O
,	O
1992	O
and	O
1994	O
.	O

its	O
successor	O
agencies	O
were	O
the	O
office	organization-government/governmentagency
of	organization-government/governmentagency
justice	organization-government/governmentagency
assistance	organization-government/governmentagency
,	organization-government/governmentagency
research	organization-government/governmentagency
,	organization-government/governmentagency
and	organization-government/governmentagency
statistics	organization-government/governmentagency
(	O
1982–1984	O
)	O
and	O
the	O
office	organization-government/governmentagency
of	organization-government/governmentagency
justice	organization-government/governmentagency
programs	organization-government/governmentagency
(	O
1984–	O
)	O
.	O

his	O
wins	O
came	O
against	O
andrew	person-athlete
ilie	person-athlete
at	O
the	O
1999	event-sportsevent
us	event-sportsevent
open	event-sportsevent
,	O
nicolas	person-athlete
mahut	person-athlete
in	O
the	O
2000	event-sportsevent
french	event-sportsevent
open	event-sportsevent
and	O
nikolay	person-athlete
davydenko	person-athlete
at	O
the	O
2002	event-sportsevent
australian	event-sportsevent
open	event-sportsevent
.	O

a	O
pooled	O
analysis	O
of	O
randomized	O
,	O
controlled	O
studies	O
of	O
meloxicam	other-medical
therapy	O
of	O
up	O
to	O
60	O
days	O
duration	O
found	O
that	O
meloxicam	other-medical
was	O
associated	O
with	O
a	O
statistically	O
significantly	O
lower	O
number	O
of	O
thromboembolic	other-medical
complications	other-medical
than	O
the	O
nsaid	other-medical
diclofenac	other-medical
(	O
0.2	O
%	O
versus	O
0.8	O
%	O
respectively	O
)	O
but	O
a	O
similar	O
incidence	O
of	O
thromboembolic	other-medical
events	O
to	O
naproxen	other-medical
and	O
piroxicam	other-medical
.	O

the	O
company	O
focused	O
most	O
of	O
its	O
efforts	O
on	O
mechanical	O
and	O
aesthetic	O
modifications	O
to	O
four	O
cars-	O
the	O
nissan	product-car
skyline	product-car
,	O
nissan	product-car
march	product-car
,	O
subaru	product-car
impreza	product-car
and	O
subaru	product-car
legacy	product-car
.	O

three	O
``	O
world	product-car
's	product-car
fastest	product-car
edition	product-car
``	O
venom	product-car
gt	product-car
coupés	O
were	O
produced	O
in	O
2014	O
to	O
commemorate	O
the	O
car	O
's	O
speed	O
record	O
run	O
.	O

however	O
,	O
until	O
2001	O
,	O
the	O
float	O
was	O
tightly	O
managed	O
by	O
the	O
central	organization-government/governmentagency
bank	organization-government/governmentagency
of	organization-government/governmentagency
egypt	organization-government/governmentagency
and	O
foreign	O
exchange	O
controls	O
were	O
in	O
effect	O
.	O

lefkowitz	organization-government/governmentagency
,	organization-government/governmentagency
j	organization-government/governmentagency
.	O

he	O
rose	O
to	O
become	O
a	O
judge	O
of	O
the	O
punjab	organization-government/governmentagency
high	organization-government/governmentagency
court	organization-government/governmentagency
in	O
1949	O
and	O
then	O
the	O
chief	O
justice	O
of	O
the	O
west	organization-government/governmentagency
pakistan	organization-government/governmentagency
high	organization-government/governmentagency
court	organization-government/governmentagency
in	O
1958	O
.	O

